National Decision Support Company and the Society of Nuclear Medicine and Molecular Imaging enter agreement for delivery of Appropriate Use Criteria

June 6, 2017

SNMMI criteria will be delivered through NDSC’s CareSelect Imaging™ Platform.

National Decision Support Company (NDSC) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced today that they have entered an agreement to make the SNMMI Imaging Appropriate Use Criteria (AUC) available to referring physicians and other medical providers.  

The Protecting Access to Medicare Act of 2014 (H.R. 43032) requires ordering professionals to consult AUC when ordering advanced imaging. Only AUC developed by entities meeting the qualified provider-led entity (PLE) standards can be used under the program. SNMMI became a qualified PLE under the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging in June 2016. 

The SNMMI AUC join NDSC’s foundational criteria set delivered through CareSelect Imaging. CareSelect Imaging contains AUC sets from multiple qualified PLEs, including the American College of Radiology (ACR Select), the American College of Cardiology, the National Comprehensive Cancer Network, and now the Society of Nuclear Medicine and Molecular Imaging.

“NDSC’s CareSelect system is the leading clinical decision support mechanism, providing access to trusted guidelines that cover a wide array of tests and services, including imaging,” said SNMMI Chief Executive Officer Virginia Pappas. “It is widely used by hospital systems, and SNMMI is delighted to partner with NDSC to provide referring physicians with access to the appropriate use criteria for nuclear medicine and molecular imaging studies.”

CareSelect Imaging is the only AUC delivery mechanism on the market with complete coverage of all CMS qualified Medical Specialty Society content. The focus on content sourced from medical specialty societies, including SNMMI, assures providers that criteria are developed through proven processes that reflect the collective experience of providers on a national scale, without bias and independent of economic agendas.

The SNMMI AUC will be available in early fall 2017 to all NDSC CareSelect Imaging users.

# # #

About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.

SNMMI’s more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.

About National Decision Support Company
National Decision Support Company delivers enterprise-wide Clinical Decision Support solutions that enable more appropriate care, improve population health, and reduce cost. NDSC’s CareSelect Imaging™ converts published guidelines into actionable criteria that is delivered directly into the EMR workflow. Criteria covers adult and pediatric patient populations featuring guidelines sourced directly from the Society for Pediatric Radiology. For more information, visit www.nationaldecisionsupport.com.

About CareSelect Imaging™
CareSelect Imaging expands on NDSC’s foundational ACR Select™ solution to deliver a comprehensive range of Appropriate Use Criteria (AUC) for diagnostic imaging in both adult and pediatric patient populations. AUC is sourced from a growing list of qualified Provider Led Entities (qPLE), including the American College of Radiology, the American College of Cardiology, the National Comprehensive Cancer Network® and the Society of Nuclear Medicine and Molecular Imaging to ensure compliance with the Protecting Access to Medicare Act of 2014 (PAMA).